Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|June 9, 2020
Urgent Hospital Admissions Caused by Adverse Drug Reactions and Medication Errors-A Population-Based Study in SpainGina Mejía, Miriam Saiz-Rodríguez, Beatriz Gómez de Olea, et al.
Journal of Clinical Psychopharmacology|September 4, 2010
Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteersJesús Novalbos, Rosario López-Rodríguez, Manuel Román, et al.
Journal of Clinical Psychopharmacology|August 27, 2011
DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteersRosario López-Rodríguez, Manuel Román, Jesús Novalbos, et al.
Pain Physician|September 23, 2021
24-month Real-World Study of Spinal Cord Stimulation in Failed Back Surgery Patients with Refractory PainConcepcion Perez, Elena Rojo, Cesar Margarit, et al.
Pharmacogenomics|June 16, 2020
Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokineticsMiriam Saiz-Rodríguez, Dolores Ochoa, Manuel Román, et al.
Basic & Clinical Pharmacology & Toxicology|September 15, 2019
Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteersDora Koller, Carmen Belmonte, Miriam Saiz-Rodríguez, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 12, 2018
Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studiesAneta Wojnicz, Carmen Belmonte, Dora Koller, et al.
Human Psychopharmacology|July 22, 2014
Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteersTeresa Cabaleiro, Dolores Ochoa, Rosario López-Rodríguez, et al.
Clinical Therapeutics|March 17, 2012
Validation of a genotyping method for analysis of TPMT polymorphismsManuel Román, Teresa Cabaleiro, Dolores Ochoa, et al.
Basic & Clinical Pharmacology & Toxicology|July 1, 2014
Polymorphisms in CYP2D6 have a greater effect on variability of risperidone pharmacokinetics than genderTeresa Cabaleiro, Dolores Ochoa, Manuel Román, et al.
Pageof 12